Ernexa Therapeutics Inc.
ERNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $8 | $11 | $17 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $2 | $1 | $1 |
| Total Curr. Assets | $2 | $10 | $14 | $19 |
| Property Plant & Equip (Net) | $1 | $33 | $1 | $3 |
| Goodwill | $2 | $2 | $2 | $2 |
| Intangibles | $0 | $0 | $0 | $6 |
| Long-Term Investments | $0 | $0 | $0 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $4 | $5 | $0 |
| Total NC Assets | $3 | $40 | $9 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5 | $49 | $22 | $32 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $2 | $2 |
| Short-Term Debt | $0 | $2 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $3 | $4 | $1 |
| Total Curr. Liab. | $3 | $7 | $8 | $4 |
| LT Debt | $0 | $40 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $40 | $3 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $35 | $1 | $3 |
| Total Liabilities | $4 | $47 | $10 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$232 | -$187 | -$165 | -$141 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $233 | $189 | $177 | $166 |
| Total Equity | $2 | $2 | $12 | $26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5 | $49 | $22 | $32 |
| Net Debt | -$1 | $34 | -$7 | -$14 |